Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dunn School Student in Science Communication Competition Regional Final

General

Using a paper crane as a prop, Fodor lab DPhil student Bernadeta Dadonaite explained the potential of DNA origami technology to a capacity audience at the FameLab 2017 regional final at the Bullingdon bar and club in Oxford on 8 March.

FameLab helps communicate science to the general public in digestible three-minute competitive performances by students and researchers across the fields of science and engineering.  Running in over 25 countries worldwide the competition started at Cheltenham Science Festival in 20015.  Science Oxford runs the Oxford heats. 

Bernadeta was one of eight regional finalists grilled by a judging panel of experts from across Oxford: John Runions,  Reader in Cell and Molecular Biology at Oxford Brookes University; Jennifer Rogers, Vice President for External Affairs at the Royal Statistical Society and Director of Statistical Consultancy Services at Oxford University; and Alison Woollard, Oxford University Academic Champion for Public Engagement with Research. YouTube science vlogger Sally le Page hosted the event.

Read more (Sir William Dunn School of Pathology website)

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Three ways virtual reality could transform mental health treatment

General Research

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.